Columnist Ben Hofmeister discusses his idea of "MS relativism" and why judging yourself based on your pre-diagnosis abilities is a bad idea.
ECTRIMS and EBMT said stem cell transplant can be considered for some with RRMS, such as those who are younger and have less severe disease.
Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...
Columnist Ahna Crum relates her years-long struggle with avascular necrosis, the reason she has a "bone to pick" with ...
The agreement will allow Enigma to use its PET imaging tracer PMI04 to visualize microglia activity in neurodegenerative ...
The U.S. Food and Drug Administration (FDA) has added a new boxed warning to the prescribing information for glatiramer acetate, an approved injection therapy for relapsing forms of multiple ...
The PoNS device led to sustained benefits in gait function in people with multiple sclerosis in a real-world study.
Tech company Century Health will organize and clean Nira Medical's datasets from more than 3,000 people with MS to aid ...
Columnist Ben Hofmeister reflects on his journey treating depression and what he wishes he knew earlier about MS and mental health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback